Therapeutic Protein–Drug Interactions and Implications for Drug Development
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference35 articles.
1. Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical Practice
2. Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling
3. New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process
Cited by 134 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal Antibodies: From Structure to Therapeutic Application;Pharmaceutical Biotechnology;2024
2. Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis;The Journal of Clinical Pharmacology;2023-11-23
3. Spectroscopy and dynamics of beta-lactoglobulin complexed with rifampicin;Journal of Biomolecular Structure and Dynamics;2023-10-30
4. Development of a Controllable Thermo-hygrostat Incubator for Bacterial Cell Culture on a Microfluidic Device;Journal of the Korean Society for Precision Engineering;2023-06-01
5. Denosumab: dosing and drug interaction challenges on the path to approval;Overcoming Obstacles in Drug Discovery and Development;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3